A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) - Meindl-Beinker, Nadja M.; Betge, Johannes; Gutting, Tobias; Burgermeister, Elke; Belle, Sebastian; Zhan, Tianzuo; Schulte, Nadine; Ebert, Matthias; Härtel, Nicolai (BioMed Central ; Springer, 2019)
In: BMC Cancer, 19 (2019), Nr. 231. pp. 1-8. ISSN 1471-2407